| Treg < 15 | Treg ≥15 | P-value |
---|---|---|---|
Tumour size (mm) | Â | Â | Â |
Median | 21.2 | 23.8 | 0.571 |
Tumour grade | Â | Â | < 0.001 |
1 | 56 (22%) | 25 (11%) | Â |
2 | 123 (47%) | 84 (38%) | Â |
3 | 80 (31%) | 115 (51%) | Â |
Nodal status | Â | Â | 0.062 |
Negative | 154 (59%) | 109 (51%) | Â |
Positive | 107 (41%) | 107 (49%) | Â |
ER | Â | Â | 0.025 |
Negative | 73 (28%) | 81 (38%) | Â |
Positive | 189 (72%) | 135 (62%) | Â |
HER2 | Â | Â | 0.002 |
Negative | 238 (97%) | 186 (90%) | Â |
Positive | 7 (3%) | 20 (10%) | Â |
CXCL12 | Â | Â | 0.008 |
Negative | 51 (41%) | 27 (25%) | Â |
Positive | 74 (59%) | 83 (75%) | Â |
Endocrine Rx | Â | Â | 0.255 |
Negative | 99 (37%) | 72 (32%) | Â |
Positive | 167 (63%) | 151 (68%) | Â |
Chemotherapy | Â | Â | 0.148 |
Negative | 168 (64%) | 127 (57%) | Â |
Positive | 96 (35%) | 95 (43%) | Â |